- ASAM CME Home Page
- Alcohol Use in HIV patients - HIV Clinical Education Initiative (CEI) discusses some of the medical problems related to the use of alcohol and other drugs with an emphasis on conditions caused or exacerbated by alcohol. Accredited for one CME credit.
- Buprenorphine Training - This is an eight-hour course and a four-hour follow-up course by ASAM.
- Drug Interactions with Hepatitis C Medications: A Self-Study Module - Independent online study for 1.0 AMA PRA Category 1 Credit TM posted 2/2012
- Evidence-Based Strategies For Treating Tobacco Dependence - This booklet, which is based on the Clinical Practice Guideline Treating Tobacco Use and Dependence, 2008 Update, will provide the reader with the information necessary to better assist patients in their attempts to quit smoking. (2.0 AMA/PRA Category One credits)
- Overdose Prevention: The Role of Naloxone in Community - Free CME Course from HIV Clinical Education
- Safe and Effective Opioid Prescribing for Chronic Pain - Free CME Course from Boston University School of Medicine
- Smoking Cessation in the HIV Patient - Understand the changing paradigm of HIV, the data on approach and management of smoking cessation among HIV patients and be familiar with smoking cessation tools.
Treating Patients with Addiction
- Biomarkers in the Treatment of Alcohol Use Disorders, 2012 Revision, The Role of - SAMHSA Advisory: Discusses the role of alcohol biomarkers in the clinical, medical, and forensic settings and examines strategies for their use and interpretation in varying circumstances such as clinical, criminal justice, and impaired healthcare provider settings.
- Clinical Drug Testing in Primary Care (SAMHSA TAP 32) - For clinical practitioners (physicians, nurse practitioners, and physician assistants) who provide primary care in office settings and community health centers. The publication provides information that practitioners need when deciding whether to introduce drug testing in their practices and gives guidance on implementing drug testing.
- Common Problems in Patients Recovering from Chemical Dependency - Prescribing and general care guidelines - American Family Physicians
- Detox: "The Next Step Toward a Better Life" - (SAMHSA) For people who are undergoing detoxification or about to leave detoxification services, this brochure provides information on what to expect following detoxification and encourages the reader to enter substance abuse treatment after detoxification.
- Impairment Assessment Tool - The Impairment assessment tool has been devised to help a program judge the likelihood of a patient/client being impaired on presentation to the program. This tool can be used in the outpatient setting or by inpatient programs on patients being admitted or returning from pass. It is meant as only a checklist of items one can consider when evaluating a patient.
- NIDAMED - Additional NIDA tools and resources for medical and health professional
- Synthetic Drug Training Package - From the Addiction Technology Transfer Center (ATTC) - the purpose of this introductory training package is to provide clinicians from a variety of work and educational backgrounds with a detailed overview of synthetic drugs.
- Getting Started with Medication-assisted Treatment (NIATx Toolkit) - Advancing Recovery: State / Provider Partnerships for Quality Addiction Care (AR) was a national initiative funded by the Robert Wood Johnson Foundation. The five-year (2005-2010) project was co-directed by the Network for the Improvement of Addiction Treatment (NIATx) at the University of Wisconsin-Madison and the Treatment Research Institute (TRI) in Philadelphia. The goal of the grant was to promote the use of evidence-based practices such as MAT through innovative partnerships between state agencies and treatment organizations. This toolkit shares lessons that emerged from the efforts of several of the grantees to establish MAT programs in their organizations.
- Treatment Improvement Protocol (TIP) 49: Incorporating Alcohol Pharmacotherapies Into Medical Practice - Written for physicians and other health care providers, presents information on the four medications approved by the FDA to treat this disease: acamprosate, disulfiram, oral naltrexone and extended-release injectable naltrexone. It describes each medication’s mechanisms of action, proper dosing, side effects and their management, indications and contraindications and patient management.
- Best Practices in the Use of Buprenorphine - This report describes the project "Development of Best Practice Guidelines for the Use of Buprenorphine in Opiate Maintenance Treatment," which was conducted by the Institute for Research, Education, and Training in Addictions (IRETA). Presents clinical guidelines that provide guidance for clinicians and payers in their efforts to improve the quality of treatment services for consumers with opiate addiction.
Here to Help - A combination of direct personal outreach and web-based services to assist patients in overcoming barriers to buprenorphine treatment and embarking on a course of long-term recovery.
- Methadone: Restricted Distribution of Methadone Hydrochloride Tablets USP 40 mg - DOJ Drug Enforcement Advisory (effective 1/1/08)
- Methadone Treatment: OASAS Medical Advisory Panel Position on QTc Interval Screening
- QT Drug List by Risk Groups - Arizona Center for Education and Research on Therapeutics
HIV and Addiction Treatment
- Bacterial Vaginosis (BV) in HIV-Infected Women NYS DOH AIDS Institute
- HIV Clinical Resources - Guidance on the Use of Buprenorphine in HIV-Infected Patients, Quick Reference Card: Screening for Substance Use in HIV-Infected Patients, Substance Use and Dependence Among HIV-Infected Adolescents and Young Adults. NYSDOH AIDS Institute
- Revised Guidelines for Starting Antiretroviral Therapy (ART) - The Medical Care Criteria Committee of the NYS AIDS Institute, which develops clinical practice guidelines for the care and treatment of HIV-positive adults in New York State, has revised its guidelines in light of recent evidence from cohort study analyses that suggest better outcomes in patients starting therapy at CD4 counts higher than the currently recommended threshold of 350 cells/mm3.
- Quick Reference Card for Insomnia Screening and Treatment in HIV-Infected Patients - Assessment and identification of insomnia in HIV-infected patients for addressing the potentially negative effects of insomnia on health, including HIV disease progression.
- HIV Testing Law 2010 - Change in state law requires health professionals to offer voluntary HIV tests to patients 13 to 64 years old. New law also simplifies informed consent process, allowing for verbal consent in some circumstances.